Viewing Study NCT03184168


Ignite Creation Date: 2025-12-24 @ 5:56 PM
Ignite Modification Date: 2026-04-08 @ 9:35 PM
Study NCT ID: NCT03184168
Status: COMPLETED
Last Update Posted: 2017-09-12
First Post: 2017-05-17
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Single-dose Study of [14C]Lorlatinib (PF-06463922) Metabolism In Healthy Male Volunteers
Sponsor: Pfizer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module